Peptide Nanomedicines for Treatment of Acute Lung Injury

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) represent a heterogenous group of lung disease in critically ill patients. Despite the increased understanding of the molecular pathogenesis of ARDS, the mortality remains unacceptably high, ranging from 34% to 64%. Hence, ARDS r...

Descripción completa

Detalles Bibliográficos
Autor principal: Sadikot, Ruxana T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149708/
https://www.ncbi.nlm.nih.gov/pubmed/22449933
http://dx.doi.org/10.1016/B978-0-12-391860-4.00016-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149708/
https://www.ncbi.nlm.nih.gov/pubmed/22449933
http://dx.doi.org/10.1016/B978-0-12-391860-4.00016-1

Ejemplares similares